health pharma news today obesity drugs glp-1 Agonists Weight Loss Market Report, 2025-2030 A new oral GLP-1 medication

These compounds are in mutual balance and have a long half-life

The practical recommendation is to apply them at different times of day (most commonly minoxidil in the morning, GHK-Cu in the evening) to give each compound a clean absorption window

References: Dimova, S., Hoet, P

As fibroblasts age, they experience a decrease in the number of receptors and become less responsive to various cellular signaling molecules (67)

The "MDCT" Combination Protocol Study (2025) This is a very recent study investigating a high-delivery method (microneedling/micro-infusion) using copper peptides as a synergistic agent alongside traditional supplements

Ultimately, Im not telling people to be more disciplined, he says